Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 28161 - 28180 out of 498429 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (S01LA05) aflibercept | Eylea 8 mg/0.07 mL injection, 0.07 mL vial | Solution for intravitreal injection 11.43 mg in 100 microlitres (114.3 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA06) brolucizumab | Beovu 6 mg/0.05 mL intraocular injection, 0.05 mL syringe | Solution for intravitreal injection 19.8 mg in 0.165 mL pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (S01LA09) faricimab | Vabysmo 6 mg/0.05 mL intraocular injection, 0.05 mL syringe | Solution for intravitreal injection 21 mg in 0.175 mL (120 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications | RocheProductsPtyLtd |
| Australia | (S01LA09) faricimab | Vabysmo 6 mg/0.05 mL intraocular injection, 0.05 mL syringe | Solution for intravitreal injection 21 mg in 0.175 mL (120 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications | RocheProductsPtyLtd |
Pages
